/
/
HealthTree Radio for AML: AML Progress in 2021 and a Look to the Future with Dr. Eytan Stein

Event Description

There is a tremendous amount of progress being made in AML. It was remarkable to see the significant work being done in the field of AML at the recent American Society of Hematology (ASH) conference in Atlanta in December 2021. 

AML expert and Director of the Program for Drug Development in Leukemia at Memorial Sloan Kettering, Dr. Eytan Stein, will share the top AML research of 2021 that was presented by himself and his colleagues at the 2021 ASH conference. He will cover a breadth of topics such as treatment options in the newly diagnosed and relapsed setting, what's been learned about maintenance therapy and MRD status, how COVID-19 is affecting AML patients and the advancements of various immunotherapies. Dr. Stein will summarize topics to consider at each phase of AML in a clear and concise way. He will end by providing us his thoughts on what AML advancements and research to look out for in 2022.  

Schedule & Agenda

12:00PM - 01:00PM
12:00PM
Katie Braswell
Welcome
Welcome, announcements and introduction
12:05PM
Dr. Eytan Stein
Interview
Dr. Eytan Stein will summarize his top AML abstracts and research projects that were presented at the 2021 American Society of Hematology conference and provide us his thoughts on what AML advancements to look out for in 2022.
12:45PM
Audience
Question and Answer Session
Audience is able to call in to the radio show (515) 602-9728 to ask Dr. Stein questions about what was discussed during our interview today.

Speakers & Moderators

The author Katie Braswell
Katie Braswell
Dallas, Texas

Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors and travel to new places.

The author Eytan Stein, MD
Eytan Stein, MD
New York, New York

Hematologist Oncologist, Director of the Program for Drug Development in Leukemia at MSKCC

Have Any Questions?

Thank you for your interest in the event. If you have any question, we would love to help! Just fill out the form below and we will get back to you as quickly as possible.

support

Get In Touch With Us

phone

(800) 930-5159

email

Support@healthtree.org

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Bristol Myers Squibb
Jazz Pharmaceuticals
AbbVie
Genentech
Amgen

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

https://www.guidestar.org/profile/45-5354811